Nearly one year ago, Ukraine’s government officially launched its medical cannabis program. Ukraine’s Parliament first approved medical cannabis reform in December 2023, with President Volodymyr Zelensky signing the measure on February 15th, 2024.

Cannabis resin, extracts, and tinctures became excluded from the list of ‘dangerous substances’ in Ukraine under the new policy after it took effect in August 2024. The production of medical cannabis, the development of medical cannabis therapies, and the distribution of medical cannabis products are tightly regulated in Ukraine.

“In order to implement the Law, the Ministry of Health team, together with the Ministry of Agrarian Policy, the State Medical Service, the Ministry of Internal Affairs, the National Police and other executive authorities, have developed by-laws that regulate all processes in detail and will allow the patient to receive medicine from medical cannabis.” Ukraine’s Ministry of Health stated in a news release at the time (translated from Ukrainian to English).

“In order to ensure the cultivation of medical cannabis in Ukraine, Licensing conditions have been developed, which will soon be considered by the Cabinet of Ministers.” the Ministry of Health also stated. “Also, the entire chain of circulation of medical cannabis, from import or cultivation to dispensing to a patient in a pharmacy, will be subject to license control.”

Another major milestone for Ukraine’s emerging medical cannabis industry came in late September 2024, when policymakers and regulators approved a list of 20 qualifying conditions for suffering patients to gain approval for the country’s medical cannabis program. In June 2025, Ukraine approved its first permit for medical cannabis product imports.

Ukraine’s Ministry of Health recently expanded the list of dosages for medical cannabis, which will afford the nation’s approved medical cannabis patients more options for treating their qualifying conditions.

“The Ministry of Health has expanded the List of dosages of medicines that can be manufactured in a pharmacy from the plant substance cannabis.” the Ministry of Health stated in a press release (translated from Ukranian to English).

“The purpose of such changes is to expand the possible options for prescribing cannabis-based medicines, which can be manufactured in a pharmacy, with combination medicines to increase the availability of treatment for patients who need it for medical reasons.” the Ministry also stated. “The updated list includes 14 forms of tetrahydrocannabinol (THC)-based medicines and 2 combined forms (based on tetrahydrocannabinol (THC) and cannabidiol (CBD).”